Trials / Completed
CompletedNCT02378649
PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
A Randomized, Placebo Controlled, Single Center Clinical Trial for Evaluation of Efficacy and Safety of Sildenafil Administration in the Cardiac ICU Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Dr. Robert Klempfner Heart Rehabilitation Institute · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, placebo controlled, single center clinical trial for evaluation of efficacy and safety of Sildenafil administration in the cardiac ICU following Mitral Valve (MV) Surgery in patients with pre-operative Significant Pulmonary Hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | Sildenafil administration in the cardiac ICU following Mitral Valve Surgery concomitant with best practice usual care |
| DRUG | Placebo | Placebo comparator concomitant with best practice usual care |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2015-03-04
- Last updated
- 2018-06-26
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02378649. Inclusion in this directory is not an endorsement.